A NOD2 gene polymorphism is associated with the prevalence and severity of chronic obstructive pulmonary disease in a Japanese population

Respirology

Volumn 17, Issue 1, 2012, Pages 164-171

  Kinose, Daisuke ^a   Ogawa, Emiko ^a,b   Hirota, Tomomitsu ^c   Ito, Isao ^a   Kudo, Megumi ^a   Haruna, Akane ^a   Marumo, Satoshi ^a   Hoshino, Yuma ^a   Muro, Shigeo ^a   Hirai, Toyohiro ^a   Sakai, Hiroaki ^a   Date, Hiroshi ^a   Tamari, Mayumi ^c   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

chronic obstructive pulmonary disease; nucleotide binding and oligomerization domain 2; single nucleotide polymorphism

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOSTIMULATION; JAPANESE; LIGAND BINDING; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; UNIVERSITY HOSPITAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 83655190180     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02069.x     Document Type: Article

References (32)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Updated 2009. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2009.
2. Lokke A, Lange P, Scharling H, et al,. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61: 935-9. (Pubitemid 44787161)
3. McCloskey SC, Patel BD, Hinchliffe SJ, et al,. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am. J. Respir. Crit. Care Med. 2001; 164: 1419-24. (Pubitemid 33124020)
4. Cosio MG, Saetta M, Agusti A,. Immunologic aspects of chronic obstructive pulmonary disease. N. Engl. J. Med. 2009; 360: 2445-54.
5. Hogg JC, Timens W,. The pathology of chronic obstructive pulmonary disease. Annu. Rev. Pathol. 2009; 4: 435-59.
6. Hasday JD, Bascom R, Costa JJ, et al,. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115: 829-35. (Pubitemid 29129968)
7. Doz E, Noulin N, Boichot E, et al,. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J. Immunol. 2008; 180: 1169-78.
8. Chamaillard M, Hashimoto M, Horie Y, et al,. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003; 4: 702-7. (Pubitemid 36874448)
9. Inohara N, Ogura Y, Fontalba A, et al,. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 2003; 278: 5509-12. (Pubitemid 36800790)
10. Girardin SE, Boneca IG, Viala J, et al,. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003; 278: 8869-72. (Pubitemid 36800360)
11. Ogura Y, Bonen DK, Inohara N, et al,. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-6. (Pubitemid 32531409)
12. Hugot JP, Chamaillard M, Zouali H, et al,. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603. (Pubitemid 32531408)
13. Hysi P, Kabesch M, Moffatt MF, et al,. NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet. 2005; 14: 935-41. (Pubitemid 40533104)
14. Braat H, Stokkers P, Hommes T, et al,. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J. Mol. Med. 2005; 83: 601-9. (Pubitemid 41176069)
15. Rozen S, Skaletsky H,. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000; 132: 365-86.
16. Rosenstiel P, Fantini M, Brautigam K, et al,. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124: 1001-9. (Pubitemid 36389803)
17. Becker S, Mundandhara S, Devlin RB, et al,. Regulation of cytokine production in human alveolar macrophages and airway epithelial cells in response to ambient air pollution particles: further mechanistic studies. Toxicol. Appl. Pharmacol. 2005; 207: 269-75.
18. Shoenfelt J, Mitkus RJ, Zeisler R, et al,. Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter. J. Leukoc. Biol. 2009; 86: 303-12.
19. Ferwerda G, Kramer M, de Jong D, et al,. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta. Eur. J. Immunol. 2008; 38: 184-91.
20. Sabbah A, Chang TH, Harnack R, et al,. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 2009; 10: 1073-80.
21. Weidinger S, Klopp N, Rummler L, et al,. Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin. Exp. Allergy 2005; 35: 866-72. (Pubitemid 41032533)
22. Ogawa E, Nakano Y, Ohara T, et al,. Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax 2009; 64: 20-5.
23. Parr DG, White AJ, Bayley DL, et al,. Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study. Respir. Res. 2006; 7: 136.
24. Tanabe N, Muro S, Hirai T, et al,. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2011; 183: 1653-9.
25. Gutierrez O, Pipaon C, Inohara N, et al,. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J. Biol. Chem. 2002; 277: 41701-5. (Pubitemid 35257477)
26. Farkas L, Stoelcker B, Jentsch N, et al,. Muramyldipeptide modulates CXCL-8 release of BEAS-2B cells via NOD2. Scand. J. Immunol. 2008; 68: 315-22.
27. Hartl D, Krauss-Etschmann S, Koller B, et al,. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J. Immunol. 2008; 181: 8053-67.
28. Ekman AK, Cardell LO,. The expression and function of Nod-like receptors in neutrophils. Immunology 2010; 130: 55-63.
29. Keatings VM, Collins PD, Scott DM, et al,. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 1996; 153: 530-4.
30. Gessner C, Scheibe R, Wotzel M, et al,. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir. Med. 2005; 99: 1229-40. (Pubitemid 41245308)
31. Donaldson GC, Seemungal TA, Patel IS, et al,. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995-2004. (Pubitemid 41507533)
32. Slevogt H, Seybold J, Tiwari KN, et al,. Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response. Cell. Microbiol. 2007; 9: 694-707. (Pubitemid 46231975)